
Hexim-CV 625 Tablet
Marketer
H & Care Incorp
Salt Composition
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Overview Hexim-CV 625 Tablet
Combiflox 625mg tablets combat diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. This prescription medication should be taken precisely as directed. Consumption with or without food is acceptable, but consistent timing optimizes effectiveness. Exceeding the prescribed dosage may be harmful. If a dose is missed, take it upon recollection. Complete the prescribed course, even with symptom improvement; premature cessation can reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and indigestion. Severe or worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (rashes, itching, swelling, breathing difficulties). Inform your physician of all current medications before commencing treatment. Pregnant or nursing individuals require medical consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Hexim-CV 625 Tablet
No text provided to rephrase.
Uses of Hexim-CV 625 Tablet
Managing bacterial infections
Major Benefits of Hexim-CV 625 Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Hexim-CV 625 Tablets can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Hexim-CV 625 Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Hexim-CV 625 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hexim-CV 625 Tablets can be consumed with or without food, although consistent timing is recommended.
How Hexim-CV 625 Tablet works:
Cefuroxime and Clavulanic Acid, combined as Hexim-CV 625 Tablets, offer a targeted antibacterial approach. Cefuroxime, an antibiotic, disrupts bacterial cell wall synthesis, a vital process for bacterial survival. Clavulanic acid, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize Cefuroxime. This synergistic effect broadens Cefuroxime's efficacy by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent alcohol and Hexim-CV 625 Tablet use.
PregnancySAFE IF PRESCRIBED
The use of Hexim-CV 625 Tablet during pregnancy is typically regarded as safe. Preclinical trials in animals have revealed minimal or no harmful consequences for the fetus; nonetheless, research involving human subjects is scant.
Breast feedingSAFE IF PRESCRIBED
Clinical data indicates Hexim-CV 625 Tablet poses minimal risk during lactation. Research in humans shows negligible transfer of the medication into breast milk, suggesting no appreciable harm to the infant.
DrivingNOT RELEVANT
Irrelevant; Hexim-CV 625 Tablets are designated for inpatient administration.
KidneyCONSULT YOUR DOCTOR
Data regarding Hexim-CV 625 Tablet use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Hexim-CV 625 Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Hexim-CV 625 Tablet :
Should you forget a dose of Hexim-CV 625 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Hexim-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
